The vasorelaxant effect of gallic acid involves endothelium-dependent and -independent mechanisms

Vascul Pharmacol. 2016 Jun:81:69-74. doi: 10.1016/j.vph.2015.10.010. Epub 2015 Nov 28.

Abstract

The mechanisms of action involved in the vasorelaxant effect of gallic acid (GA) were examined in the isolated rat thoracic aorta. GA exerted a relaxant effect in the highest concentrations (0.4-10mM) in both endothelium-intact and endothelium-denuded aortic rings. Pre-incubation with L-NAME, ODQ, calmidazolium, TEA, 4-aminopyridine, and barium chloride significantly reduced the pEC50 values. Moreover, this effect was not modified by indomethacin, wortmannin, PP2, glibenclamide, or paxillin. Pre-incubation of GA (1, 3, and 10mM) in a Ca(2+)-free Krebs solution attenuated CaCl2-induced contractions and blocked BAY K8644-induced vascular contractions, but it did not inhibit a contraction induced by the release of Ca(2+) from the sarcoplasmatic reticulum stores. In addition, a Western blot analysis showed that GA induces phosphorylation of eNOS in rat thoracic aorta. These results suggest that GA induces relaxation in rat aortic rings through an endothelium-dependent pathway, resulting in eNOS phosphorylation and opening potassium channels. Additionally, the relaxant effect by an endothelium-independent pathway involves the blockade of the Ca(2+) influx via L-type Ca(2+) channels.

Keywords: Calcium channel; Gallic acid; Nitric oxide; Potassium channels; Rat thoracic aorta; Vasorelaxant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta, Thoracic / drug effects*
  • Aorta, Thoracic / metabolism
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / drug effects
  • Calcium Channels, L-Type / metabolism
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • Female
  • Gallic Acid / pharmacology*
  • In Vitro Techniques
  • Nitric Oxide Synthase Type III / metabolism
  • Phosphorylation
  • Potassium Channels / agonists
  • Potassium Channels / metabolism
  • Rats, Wistar
  • Signal Transduction / drug effects
  • Vasodilation / drug effects*
  • Vasodilator Agents / pharmacology*

Substances

  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Potassium Channels
  • Vasodilator Agents
  • Gallic Acid
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat